
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism
Ffolliott M. Fisher, Mi-Sung Kim, Ludivine Doridot, et al.
Molecular Metabolism (2016) Vol. 6, Iss. 1, pp. 14-21
Open Access | Times Cited: 143
Ffolliott M. Fisher, Mi-Sung Kim, Ludivine Doridot, et al.
Molecular Metabolism (2016) Vol. 6, Iss. 1, pp. 14-21
Open Access | Times Cited: 143
Showing 1-25 of 143 citing articles:
Fructose and sugar: A major mediator of non-alcoholic fatty liver disease
Thomas Jensen, Manal F. Abdelmalek, Shelby Sullivan, et al.
Journal of Hepatology (2018) Vol. 68, Iss. 5, pp. 1063-1075
Open Access | Times Cited: 785
Thomas Jensen, Manal F. Abdelmalek, Shelby Sullivan, et al.
Journal of Hepatology (2018) Vol. 68, Iss. 5, pp. 1063-1075
Open Access | Times Cited: 785
Molecular pathways of nonalcoholic fatty liver disease development and progression
Fernando Bessone, María Valeria Razori, Marcelo G. Roma
Cellular and Molecular Life Sciences (2018) Vol. 76, Iss. 1, pp. 99-128
Closed Access | Times Cited: 470
Fernando Bessone, María Valeria Razori, Marcelo G. Roma
Cellular and Molecular Life Sciences (2018) Vol. 76, Iss. 1, pp. 99-128
Closed Access | Times Cited: 470
Fructose metabolism and metabolic disease
Sarah Anissa Hannou, Danielle E. Haslam, Nicola M. McKeown, et al.
Journal of Clinical Investigation (2018) Vol. 128, Iss. 2, pp. 545-555
Open Access | Times Cited: 465
Sarah Anissa Hannou, Danielle E. Haslam, Nicola M. McKeown, et al.
Journal of Clinical Investigation (2018) Vol. 128, Iss. 2, pp. 545-555
Open Access | Times Cited: 465
Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease
Kasper W. ter Horst, Mireille J. Serlie
Nutrients (2017) Vol. 9, Iss. 9, pp. 981-981
Open Access | Times Cited: 329
Kasper W. ter Horst, Mireille J. Serlie
Nutrients (2017) Vol. 9, Iss. 9, pp. 981-981
Open Access | Times Cited: 329
Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling
Samir Softic, Manoj K. Gupta, Guo-Xiao Wang, et al.
Journal of Clinical Investigation (2017) Vol. 127, Iss. 11, pp. 4059-4074
Open Access | Times Cited: 281
Samir Softic, Manoj K. Gupta, Guo-Xiao Wang, et al.
Journal of Clinical Investigation (2017) Vol. 127, Iss. 11, pp. 4059-4074
Open Access | Times Cited: 281
The adverse metabolic effects of branched-chain amino acids are mediated by isoleucine and valine
Deyang Yu, Nicole E. Richardson, Cara L. Green, et al.
Cell Metabolism (2021) Vol. 33, Iss. 5, pp. 905-922.e6
Open Access | Times Cited: 271
Deyang Yu, Nicole E. Richardson, Cara L. Green, et al.
Cell Metabolism (2021) Vol. 33, Iss. 5, pp. 905-922.e6
Open Access | Times Cited: 271
Aldolase B-Mediated Fructose Metabolism Drives Metabolic Reprogramming of Colon Cancer Liver Metastasis
Pengcheng Bu, Kai‐Yuan Chen, Kun Xiang, et al.
Cell Metabolism (2018) Vol. 27, Iss. 6, pp. 1249-1262.e4
Open Access | Times Cited: 252
Pengcheng Bu, Kai‐Yuan Chen, Kun Xiang, et al.
Cell Metabolism (2018) Vol. 27, Iss. 6, pp. 1249-1262.e4
Open Access | Times Cited: 252
Dietary Fructose and the Metabolic Syndrome
Marja‐Riitta Taskinen, Chris J. Packard, Jan Borén
Nutrients (2019) Vol. 11, Iss. 9, pp. 1987-1987
Open Access | Times Cited: 245
Marja‐Riitta Taskinen, Chris J. Packard, Jan Borén
Nutrients (2019) Vol. 11, Iss. 9, pp. 1987-1987
Open Access | Times Cited: 245
Fibroblast Growth Factor 21—Metabolic Role in Mice and Men
Harald Staiger, Michaela Keuper, Lucia Berti, et al.
Endocrine Reviews (2017) Vol. 38, Iss. 5, pp. 468-488
Open Access | Times Cited: 233
Harald Staiger, Michaela Keuper, Lucia Berti, et al.
Endocrine Reviews (2017) Vol. 38, Iss. 5, pp. 468-488
Open Access | Times Cited: 233
A Dozen Years of Discovery: Insights into the Physiology and Pharmacology of FGF21
Steven A. Kliewer, David J. Mangelsdorf
Cell Metabolism (2019) Vol. 29, Iss. 2, pp. 246-253
Open Access | Times Cited: 216
Steven A. Kliewer, David J. Mangelsdorf
Cell Metabolism (2019) Vol. 29, Iss. 2, pp. 246-253
Open Access | Times Cited: 216
Metabolic Messengers: FGF21
Kyle H. Flippo, Matthew J. Potthoff
Nature Metabolism (2021) Vol. 3, Iss. 3, pp. 309-317
Open Access | Times Cited: 201
Kyle H. Flippo, Matthew J. Potthoff
Nature Metabolism (2021) Vol. 3, Iss. 3, pp. 309-317
Open Access | Times Cited: 201
Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis
Lucas D. BonDurant, Matthew J. Potthoff
Annual Review of Nutrition (2018) Vol. 38, Iss. 1, pp. 173-196
Open Access | Times Cited: 176
Lucas D. BonDurant, Matthew J. Potthoff
Annual Review of Nutrition (2018) Vol. 38, Iss. 1, pp. 173-196
Open Access | Times Cited: 176
FGF21: An Emerging Therapeutic Target for Non-Alcoholic Steatohepatitis and Related Metabolic Diseases
Erik J. Tillman, Timothy P. Rolph
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 165
Erik J. Tillman, Timothy P. Rolph
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 165
Diet and exercise in NAFLD/NASH: Beyond the obvious
Georg Semmler, Christian Datz, Thomas Reiberger, et al.
Liver International (2021) Vol. 41, Iss. 10, pp. 2249-2268
Open Access | Times Cited: 119
Georg Semmler, Christian Datz, Thomas Reiberger, et al.
Liver International (2021) Vol. 41, Iss. 10, pp. 2249-2268
Open Access | Times Cited: 119
Fructose and the Liver
Pablo Muriel, Pedro López‐Sánchez, Erika Ramos‐Tovar
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6969-6969
Open Access | Times Cited: 110
Pablo Muriel, Pedro López‐Sánchez, Erika Ramos‐Tovar
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6969-6969
Open Access | Times Cited: 110
Chronic Inflammation—A Link between Nonalcoholic Fatty Liver Disease (NAFLD) and Dysfunctional Adipose Tissue
Maria Denisa Petrescu, Sonia I. Vlaicu, Lorena Ciumărnean, et al.
Medicina (2022) Vol. 58, Iss. 5, pp. 641-641
Open Access | Times Cited: 84
Maria Denisa Petrescu, Sonia I. Vlaicu, Lorena Ciumărnean, et al.
Medicina (2022) Vol. 58, Iss. 5, pp. 641-641
Open Access | Times Cited: 84
The role of ChREBP in carbohydrate sensing and NAFLD development
Marion Régnier, Thaïs Carbinatti, Lucia Parlati, et al.
Nature Reviews Endocrinology (2023) Vol. 19, Iss. 6, pp. 336-349
Closed Access | Times Cited: 48
Marion Régnier, Thaïs Carbinatti, Lucia Parlati, et al.
Nature Reviews Endocrinology (2023) Vol. 19, Iss. 6, pp. 336-349
Closed Access | Times Cited: 48
Going Back to the Biology of FGF21: New Insights
Jo E. Lewis, Francis J. P. Ebling, Ricardo J. Samms, et al.
Trends in Endocrinology and Metabolism (2019) Vol. 30, Iss. 8, pp. 491-504
Open Access | Times Cited: 138
Jo E. Lewis, Francis J. P. Ebling, Ricardo J. Samms, et al.
Trends in Endocrinology and Metabolism (2019) Vol. 30, Iss. 8, pp. 491-504
Open Access | Times Cited: 138
Fibroblast growth factor 21 (FGF21) is robustly induced by ethanol and has a protective role in ethanol associated liver injury
Bhavna N. Desai, Garima Singhal, Mikiko Watanabe, et al.
Molecular Metabolism (2017) Vol. 6, Iss. 11, pp. 1395-1406
Open Access | Times Cited: 126
Bhavna N. Desai, Garima Singhal, Mikiko Watanabe, et al.
Molecular Metabolism (2017) Vol. 6, Iss. 11, pp. 1395-1406
Open Access | Times Cited: 126
Metabolic Targets in Nonalcoholic Fatty Liver Disease
William P. Esler, Kendra K. Bence
Cellular and Molecular Gastroenterology and Hepatology (2019) Vol. 8, Iss. 2, pp. 247-267
Open Access | Times Cited: 122
William P. Esler, Kendra K. Bence
Cellular and Molecular Gastroenterology and Hepatology (2019) Vol. 8, Iss. 2, pp. 247-267
Open Access | Times Cited: 122
The FGF metabolic axis
Xiaokun Li
Frontiers of Medicine (2019) Vol. 13, Iss. 5, pp. 511-530
Open Access | Times Cited: 120
Xiaokun Li
Frontiers of Medicine (2019) Vol. 13, Iss. 5, pp. 511-530
Open Access | Times Cited: 120
FGF21 Signals to Glutamatergic Neurons in the Ventromedial Hypothalamus to Suppress Carbohydrate Intake
Sharon O. Jensen-Cody, Kyle H. Flippo, Kristin E. Claflin, et al.
Cell Metabolism (2020) Vol. 32, Iss. 2, pp. 273-286.e6
Open Access | Times Cited: 110
Sharon O. Jensen-Cody, Kyle H. Flippo, Kristin E. Claflin, et al.
Cell Metabolism (2020) Vol. 32, Iss. 2, pp. 273-286.e6
Open Access | Times Cited: 110
ChREBP-Mediated Regulation of Lipid Metabolism: Involvement of the Gut Microbiota, Liver, and Adipose Tissue
Katsumi Iizuka, Ken Takao, Daisuke Yabe
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 103
Katsumi Iizuka, Ken Takao, Daisuke Yabe
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 103
Hepatic regulation of VLDL receptor by PPARβ/δ and FGF21 modulates non-alcoholic fatty liver disease
Mohammad Zarei, Emma Barroso, Xavier Palomer, et al.
Molecular Metabolism (2017) Vol. 8, pp. 117-131
Open Access | Times Cited: 96
Mohammad Zarei, Emma Barroso, Xavier Palomer, et al.
Molecular Metabolism (2017) Vol. 8, pp. 117-131
Open Access | Times Cited: 96
Restriction of essential amino acids dictates the systemic metabolic response to dietary protein dilution
Yann Wan Yap, Patricia M. Rusu, Andrea Y. Chan, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 92
Yann Wan Yap, Patricia M. Rusu, Andrea Y. Chan, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 92